|View printer-friendly version|
|Implant Sciences Receives Multiple Orders for QS-H150 Explosives Detectors|
Important New and Repeat Business in China
Implant Sciences Corporation (OTCBB:IMSC), a high technology supplier of systems and sensors for homeland security markets, today announced that the company has received multiple orders totaling approximately $400,000 for its Quantum Sniffer™ QS-H150 Portable Explosives Detectors. The devices will be delivered to governmental customers of Implant Sciences’ distributors in China. The QS-H150’s are expected to be deployed for use in Law Enforcement and Aviation Security applications in multiple locations throughout China.
"This is a strategic win for the Company as it represents success of our new Law Enforcement initiatives as well as follow-on business from an important Aviation Security customer."
Glenn D. Bolduc, Implant Sciences’ President and CEO, commented, "This is a strategic win for the Company as it represents success of our new Law Enforcement initiatives as well as follow-on business from an important Aviation Security customer." He added, "This is a competitive win as well, because the Company’s products are more and more often being selected over other products due to technical and operational advantages."
The QS-H150 provides high performance and reliability combined with ease-of-use and very low costs of ownership. Annual maintenance costs are minimal and consist primarily of normal care and cleaning using common supplies. Calibration is autonomous, continuous, and requires no consumables. Since there are no radioactive materials used in the QS-H150, there are no associated certifications, licenses, inspections, or end-of-life disposal issues. As such, customers have an outstanding, cost effective product available to them in support of efforts to improve their overall security profile and meet mission critical objectives.
About Implant Sciences
Implant Sciences develops, manufactures and sells sophisticated sensors and systems for the Security, Safety and Defense (SS&D) industries. The Company has developed proprietary technologies used in its commercial portable and bench-top explosive trace detection systems which ship to a growing number of locations domestically and internationally. For further details on the Company and its products, please visit the Company's website at www.implantsciences.com.
Safe Harbor Statement
This press release may contain certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that we have defaulted on our indebtedness to our secured lender, DMRJ Group; if we are unable to satisfy our obligations to DMRJ and to raise additional capital to fund operations, our business may fail; we continue to incur substantial operating losses and may never be profitable; the delisting of our common stock by the NYSE Amex has limited our stock’s liquidity and has impaired our ability to raise capital; our explosives detection products and technologies may not be accepted by the U.S. government or by other government agencies or commercial consumers of security products; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including its most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.